// App-Quantinova.ai

S2046 2016 AHA : Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients With Type 2 Diabetes and Acute Coronary Syndrome: Analysis From Elixa and Importance of Duration of Diabetes

Researchers

Presenter

  • Rhonda Bentley-Lewis

Principal Investigators

  • Brian Claggett

  • Matthew C Riddle

  • Scott D. Solomon

  • Jean-Claude Tardif

  • Marc A. Pfeffer

  • Rafael Diaz

  • Hertzel C. Gerstein

  • Lars V. Kober

  • Francesca C Lawson

  • Eldrin F Lewis

  • Aldo P Maggioni

  • John J.V. McMurray

  • Jeffrey L. Probstfield

Medical Centers

  • Brigham & Women's Hospital, Boston, MA

  • Canada, ON, Hamilton, McMaster Univ, Hamilton, ON, Canada

  • Univ de Montreal and Montreal Heart Inst, Montreal, QC, Canada

  • University of Washington Medical Center, Seattle, WA

  • Oregon Health and Science University, Portland, OR

  • Estudios Clinicos Latino America (ECLA), Rosario, Argentina

  • British Heart Fndn Cardiovascular Res Ctr, Univ of Glasgow, Glasgow, United Kingdom

  • Massachusetts General Hosp Harvard Medcl School, Boston, MA

  • Res Ctr of the Italian Association of Hosp Cardiologists, Florence, Italy

Locations

  • Canada

  • Argentina

  • Italy

  • United Kingdom

  • United States

Companies

  • Sanofi S.A.

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Type 2 diabetes mellitus

  • Angina

  • Diabetic retinopathy

  • Peripheral neuropathy

  • Diabetes

  • Stroke

Biomarkers

  • Creatinine

  • Ret Proto-Oncogene

  • Hemoglobin A1c

  • Human albumin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT01147250

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved